| Citation: |
WU Qingyun, SU Qiang. Research advances in diagnostic methods for myocardial ischemia-reperfusion without reflow[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2024, 45(4): 424-429. DOI: 10.12435/j.issn.2095-5227.2024.018
|
In recent years, the incidence and mortality of cardiovascular events are increasing. Acute coronary syndrome (ACS), as one of the acute and critical illnesses of cardiovascular system, has an aggressive onset and a high mortality rate. Percutaneous coronary intervention is an effective treatment for patients with ACS, which can open the occluded vessels in time, realize myocardial reperfusion, and significantly reduce the mortality rate. However, the occurrence of coronary artery no-reflow after hemodialysis is an important cause of increased mortality in ACS. Early diagnosis of no-reflow is critical for urgent reperfusion therapy. Coronary angiography is the most direct method to diagnose no-reflow in the catheterization laboratory and is one of the commonly used diagnostic measures in clinical practice at this stage. Intracoronary physiologic assessment is based on the principles of coronary hemodynamics, which assesses the blood supply function of the heart by measuring coronary blood flow velocity and coronary pressure. In addition, the rise of many non-invasive cardiac imaging techniques has provided a broad application prospect for the diagnosis of no-reflow. In this article, we systematically summarize and analyze the recent advances and current challenges of diagnostic methods such as TIMI flow grading, corrected TIMI frame rate, coronary flow reserve, microcirculatory resistance index, electrocardiography, and cardiovascular magnetic resonance imaging, with the aim of providing a reference for early diagnosis and comprehensive assessment of anelectasis.
| [1] |
Zhang QY,Hu MR,Ma SM,et al. New R2-CHA2DS2-VASc score predicts no-reflow phenomenon and long-term prognosis in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention[J]. Front Cardiovasc Med,2022,9: 899739. doi: 10.3389/fcvm.2022.899739
|
| [2] |
Ndrepepa G,Cassese S,Xhepa E,et al. Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y12 inhibitors[J/OL]. https://doi.org/10.1007/s00392-023-02340-y.
|
| [3] |
Liu YH,Ye T,Chen K,et al. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis[J]. Front Cardiovasc Med,2022,9: 966299. doi: 10.3389/fcvm.2022.966299
|
| [4] |
Korte N,Ilkan Z,Pearson CL,et al. The Ca2 + -gated channel TMEM16A amplifies capillary pericyte contraction and reduces cerebral blood flow after ischemia[J]. J Clin Invest,2022,132(9): e154118. doi: 10.1172/JCI154118
|
| [5] |
Ndrepepa G,Colleran R,Kastrati A. No-reflow after percutaneous coronary intervention:a correlate of poor outcome in both persistent and transient forms[J]. EuroIntervention,2018,14(2): 139-141. doi: 10.4244/EIJV14I2A21
|
| [6] |
杨跃进. 冠状动脉无复流现象[J]. 内科急危重症杂志,2015,21(6): 401-403.
|
| [7] |
Hu F,Lu F,Huang X,et al. Relationship between plasma total homocysteine levels and mean corrected TIMI frame count in patients with acute myocardial infarction[J]. Int J Gen Med,2021,14: 8161-8172. doi: 10.2147/IJGM.S338938
|
| [8] |
Poyraz E,Savaş G,Erdem A,et al. The mean corrected TIMI frame count could predict major adverse cardiovascular events in patients with coronary slow-flow phenomenon[J]. Turk Kardiyol Dern Ars,2022,50(4): 250-255. doi: 10.5543/tkda.2022.21309
|
| [9] |
Li XH,Lyu LJ,Yang W,et al. Identification of flow-limiting coronary stenosis with PCS:a new cost-effective index derived from the product of corrected TIMI frame count and percent diameter stenosis[J]. Front Cardiovasc Med,2021,8: 718935. doi: 10.3389/fcvm.2021.718935
|
| [10] |
Arefin MM,Rahman A,Kundu SK,et al. Impact of myocardial blush grade on In-hospital outcome after primary percutaneous coronary intervention[J]. Mymensingh Med J,2022,31(1): 172-179.
|
| [11] |
Vera Cruz P,Palmes P,Bacalangco N. Prognostic value of myocardial blush grade in ST-elevation MI:a systematic review and meta-analysis[J]. Interv Cardiol,2022,17: e10. doi: 10.15420/icr.2022.01
|
| [12] |
Zhou LP,Hu XM,Zhang HT,et al. Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction[J]. J Int Med Res,2023,51(6):3000605231182547.
|
| [13] |
Batra G,Renlund H,Kunadian V,et al. Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome:results from the PLATelet inhibition and patients Outcomes (PLATO) trial[J]. Eur Heart J Acute Cardiovasc Care,2022,11(4): 336-349. doi: 10.1093/ehjacc/zuac020
|
| [14] |
Tomasik A,Nabrdalik K,Kwiendacz H,et al. Effect of diabetes mellitus and left ventricular perfusion on frequency of development of heart failure and/or all-cause mortality late after acute myocardial infarction[J]. Am J Cardiol,2021,140: 25-32. doi: 10.1016/j.amjcard.2020.10.051
|
| [15] |
Nabrdalik K,Tomasik A,Irlik K,et al. Low Quantitative Blush Evaluator score predicts larger infarct size and reduced left ventricular systolic function in patients with STEMI regardless of diabetes status[J]. Sci Rep,2023,13(1): 250. doi: 10.1038/s41598-022-24855-6
|
| [16] |
Masdjedi K,van Zandvoort LJ,Balbi MM,et al. Validation of novel 3-dimensional quantitative coronary angiography based software to calculate fractional flow reserve post stenting[J]. Catheter Cardiovasc Interv,2021,98(4): 671-677.
|
| [17] |
Tufaro V,Safi H,Torii R,et al. Wall shear stress estimated by 3D-QCA can predict cardiovascular events in lesions with borderline negative fractional flow reserve[J]. Atherosclerosis,2021,322: 24-30. doi: 10.1016/j.atherosclerosis.2021.02.018
|
| [18] |
de Moura Santos L,Borges Carvalho W Jr,Ribeiro MH,et al. Offline assessment of the quantitative flow ratio:is it useful in clinical practice?[J]. J Invasive Cardiol,2022,34(8): E620-E626.
|
| [19] |
Koo BK,Yang S. Doppler vs thermodilution for coronary flow reserve:does the end justify the means?[J]. JACC Cardiovasc Interv,2022,15(10): 1071-1073. doi: 10.1016/j.jcin.2022.04.012
|
| [20] |
Tar B,Ágoston A,Üveges Á,et al. Pressure- and 3D-derived coronary flow reserve with hydrostatic pressure correction:comparison with intracoronary Doppler measurements[J]. J Pers Med,2022,12(5): 780. doi: 10.3390/jpm12050780
|
| [21] |
Torralba EI,Barrios AG,Crespo FR,et al. CRT-100.21 coronary flow reserve assessed by continuous thermodilution method[J]. JACC Cardiovasc Interv,2023,16(4): S34.
|
| [22] |
Kelshiker MA,Seligman H,Howard JP,et al. Coronary flow reserve and cardiovascular outcomes:a systematic review and meta-analysis[J]. Eur Heart J,2022,43(16): 1582-1593. doi: 10.1093/eurheartj/ehab775
|
| [23] |
Gallinoro E,Bertolone DT,Fernandez-Peregrina E,et al. Reproducibility of bolus versus continuous thermodilution for assessment of coronary microvascular function in patients with ANOCA[J]. EuroIntervention,2023,19(2): e155-e166. doi: 10.4244/EIJ-D-22-00772
|
| [24] |
Rivero F,Gutiérrez-Barrios A,Gomez-Lara J,et al. Coronary microvascular dysfunction assessed by continuous intracoronary thermodilution:a comparative study with index of microvascular resistance[J]. Int J Cardiol,2021,333: 1-7. doi: 10.1016/j.ijcard.2021.03.005
|
| [25] |
Jeyaprakash P,Mikhail P,Ford TJ,et al. The index of microcirculatory resistance stratifies the presence of microvascular obstruction in st-elevation myocardial infarction:a systematic review and meta-analysis[J]. J Am Coll Cardiol,2022,79(9): 1101. doi: 10.1016/S0735-1097(22)02092-7
|
| [26] |
Choi SH,Yoon GS,Yoon MH,et al. CRT-100.29 the role of index of microcirculatory resistance in left anterior descending artery ST segment elevation myocardial infarction patients with thrombolysis in myocardial infarction myocardial perfusion grade 3 after primary percutaneous coronary intervention[J]. JACC Cardiovasc Interv,2023,16(4): S6.
|
| [27] |
Choi KH,Dai N,Li YL,et al. Functional coronary angiography-derived index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction[J]. JACC Cardiovasc Interv,2021,14(15): 1670-1684. doi: 10.1016/j.jcin.2021.05.027
|
| [28] |
Tas A,Broyd CJ,Alan Y,et al. Non-hyperaemic coronary flow velocity acceleration indices correlate with hyperaemic microvascular resistance in patients with INOCA[J]. Eur Heart J,2023,44(Supplement_2): ehad655.1189. doi: 10.1093/eurheartj/ehad655.1189
|
| [29] |
Feenstra RGT,Seitz A,Boerhout CKM,et al. Reference values for intracoronary Doppler flow velocity-derived hyperaemic microvascular resistance index[J]. Int J Cardiol,2023,371: 16-20. doi: 10.1016/j.ijcard.2022.09.054
|
| [30] |
Yamazaki T,Saito Y,Yamashita D,et al. Factors associated with impaired resistive reserve ratio and microvascular resistance reserve[J]. Diagnostics,2023,13(5): 950. doi: 10.3390/diagnostics13050950
|
| [31] |
Konijnenberg LSF,Damman P,Duncker DJ,et al. Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction[J]. Cardiovasc Res,2020,116(4): 787-805. doi: 10.1093/cvr/cvz301
|
| [32] |
Sezer M,Escaned J,Broyd CJ,et al. Gradual versus abrupt reperfusion during primary percutaneous coronary interventions in ST-segment-elevation myocardial infarction (GUARD)[J]. J Am Heart Assoc,2022,11(10): e024172. doi: 10.1161/JAHA.121.024172
|
| [33] |
Annibali G,Scrocca I,Aranzulla TC,et al. “No-reflow” phenomenon:a contemporary review[J]. J Clin Med,2022,11(8): 2233. doi: 10.3390/jcm11082233
|
| [34] |
Shaikh MK,Ali Shah SZ,Kumar C,et al. Accuracy of resolution of ST-segment elevation in electrocardiogram to determine the patency of infarct-related artery[J]. Cureus,2021,13(4): e14448.
|
| [35] |
Wu C,Gao XJ,Li L,et al. Role of ST-segment resolution alone and in combination with TIMI flow after primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction[J]. J Am Heart Assoc,2023,12(14): e029670. doi: 10.1161/JAHA.123.029670
|
| [36] |
Ismail TF,Strugnell W,Coletti C,et al. Cardiac MR:from theory to practice[J]. Front Cardiovasc Med,2022,9: 826283. doi: 10.3389/fcvm.2022.826283
|
| [37] |
Manisty CH,Jordan JH,Hundley WG. Automated noncontrast myocardial tissue characterization for hypertrophic cardiomyopathy:holy grail or false prophet?[J]. Circulation,2021,144(8): 600-603. doi: 10.1161/CIRCULATIONAHA.121.055791
|
| [38] |
Mayr A,Klug G,Reindl M,et al. Evolution of myocardial tissue injury:a CMR study over a decade after STEMI[J]. JACC Cardiovasc Imaging,2022,15(6): 1030-1042. doi: 10.1016/j.jcmg.2022.02.010
|
| [39] |
Gräni C,Stark AW,Fischer K,et al. Diagnostic performance of cardiac magnetic resonance segmental myocardial strain for detecting microvascular obstruction and late gadolinium enhancement in patients presenting after a ST-elevation myocardial infarction[J]. Front Cardiovasc Med,2022,9: 909204. doi: 10.3389/fcvm.2022.909204
|
| [40] |
Ndrepepa G,Kastrati A. Coronary No-reflow after primary percutaneous coronary intervention-current knowledge on pathophysiology,diagnosis,clinical impact and therapy[J]. J Clin Med,2023,12(17): 5592. doi: 10.3390/jcm12175592
|
| [41] |
Capdeville S,Gholson BA,Lindner JR. Contrast echocardiography for assessing myocardial perfusion[J]. Curr Cardiol Rep,2023,25(11): 1581-1587. doi: 10.1007/s11886-023-01970-y
|
| [42] |
Krinochkin D,Bessonov I,Yaroslavskaya E,et al. Assessment of no-reflow phenomenon by myocardial contrast echocardiography in patients with acute myocardial infarction with ST-segment elevation[J]. Eur Heart J Cardiovasc Imaging,2021,22(Supplement_1): jeaa356.105. doi: 10.1093/ehjci/jeaa356.105
|
| [43] |
Wang L,Ma YL,Jin WY,et al. Coronary microcirculation dysfunction evaluated by myocardial contrast echocardiography predicts poor prognosis in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention[J]. BMC Cardiovasc Disord,2022,22(1): 572. doi: 10.1186/s12872-022-02947-5
|
| [44] |
Chowdhary A,Garg P,Das A,et al. Cardiovascular magnetic resonance imaging:emerging techniques and applications[J]. Heart,2021,107(9): 697-704. doi: 10.1136/heartjnl-2019-315669
|
Copyright © Editorial Department of Journal of PLA Medical College 京ICP备17052889号-1
Supported by: Beijing Renhe Information Technology Co.,
Ltd. 
DownLoad: